Article
Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome.
Diabetes - 1 Jul 2004
Kaisaki Pamela J, Delépine Marc, Woon Peng Y, Sebag-Montefiore Liam, Wilder Steven P, Menzel Stephan, Vionnet Nathalie, Marion Evelyne, Riveline Jean-Pierre, Charpentier Guillaume, Schurmans Stéphane, Levy Jonathan C, Lathrop Mark, Farrall Martin, Gauguier Dominique
Abstract excerpt
Type II SH2 domain-containing inositol 5-phosphatase (INPPL1, or SHIP2) plays an important role in the control of insulin sensitivity. INPPL1 mutations affecting gene function have been found in rat models of type 2 diabetes and hypertension and in type 2 diabetic patients. We investigated the influence of nucleotide variation in INPPL1 on components of the metabolic syndrome. Following comprehensive resequencing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
